Was ist die Webseite?

SHL Medical

Startseite
Schweiz
Zug
SHL Medical

SHL Medical is a world-leading designer, developer, and manufacturer of autoinjectors, pen injectors, and advanced wearable drug delivery systems.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Headquartered in Switzerland with sites across three continents, we offer end-to-end services, from design and development to final assembly, labeling, and packaging, partnering with pharma companies to deliver self-injection systems that enable patients’ independence. View SHL Medical trademarks: https://www.shl-medical.com/trademarks

30/01/2026

Together with Tech Cluster Zug AG, we recently celebrated a major milestone in the establishment of our new European manufacturing site in Zug, Switzerland: the topping-out of our six‑storey office and production facility, marking the completion of the building’s structural shell.

The event brought together around 300 project partners, underscoring both the strong collaboration behind this project and the significant progress made to date. Once completed, the new SHL Medical headquarters will bring development, production, and administration together under one state‑of‑the‑art roof.

As a central hub for innovation, research, and development, the new Zug site will play a pivotal role in advancing the next generation of drug delivery solutions – strengthening our capabilities and bringing us even closer to our European customers.

29/01/2026

Innovation in manufacturing doesn’t start with machines – it starts with people.

For Tobias Meier, Senior Project Engineer, this means growing his expertise while shaping solutions that make a real difference in patients’ lives. At SHL Medical, he develops and industrializes injection molding processes: From setting up new molding infrastructure to improving automated manufacturing systems, Tobias helps ensure production can scale reliably and perform consistently over time.

Collaboration sits at the core of his work. Partnering closely with global teams, Tobias helps translate product and process needs into manufacturing reality. This is most evident in his work supporting our new site in Zug, Switzerland, where progress depends on ownership and close collaboration across functions.

At SHL Medical, we create a space where people grow their skills, rely on each other, and see the impact of their work come to life. 🙌

28/01/2026

Design choices matter in once-weekly cardiometabolic delivery. At Pharmapack 2026, discussions highlighted how Quanta supports these needs through intentional design choices.

Key design features of Quanta include:
🔷 Automatic injection
🔷 No-priming design
🔷 Fixed-dose delivery
🔷 Multiple-dose capability

Watch the video 👇 to see how they come together.

27/01/2026

In Paris, Quanta sparked the kind of discussion that matters in cardiometabolic delivery: usability, consistent dosing, and repeatable performance.

In this short reflection, Bart Burgess, Senior Vice President, Innovation and Product Strategy at SHL Medical shares the design intent behind Quanta, informed by what users need and what SHL Medical has learned from the market over time.

26/01/2026

On the International Day of Clean Energy, SHL Medical celebrates continued progress in integrating clean energy across electricity sourcing, energy efficiency, and electrification initiatives.

🔋 Over the past two years, renewable electricity use across our sites has approximately doubled. All SHL Medical-operated EU and US sites, including manufacturing, are powered by 100% renewable electricity, while work continues toward achieving full renewable electricity coverage across all sites by 2030.

⚙️ Guided by site-level energy audits, we are implementing targeted energy efficiency and electrification measures. These include HVAC and equipment optimization, as well as fleet electrification, to reduce energy consumption and associated Scope 1 and 2 emissions while supporting continued business growth.

Together, these efforts reinforce our focus on reducing emissions and strengthening the sustainability of our business. Happy International Day of Clean Energy!

24/01/2026

At SHL Medical, quality is built into our culture. From product development and manufacturing to everyday decision-making, our teams operate to shared quality standards to help pharma move forward with confidence.

That work is powered by our quality teams: Quality Engineering teams focus on reducing risk early by establishing robust quality systems during product and process development, while Quality Assurance teams work across functions to ensure that products, processes, and decisions remain aligned with regulatory requirements throughout the device lifecycle.

As part of this quality culture, our teams in Taiwan will be connecting with future talents through campus activities, sharing how quality at SHL Medical helps shape dependable device programs at scale.

Learn more about how our teams work together to build quality into everything we do: https://www.shl-medical.com/careers/teams?utm_source=linkedin&utm_medium=social&utm_campaign=organic_content&utm_content=multiimage_post_012426

23/01/2026

As cardiometabolic therapies grows rapidly and reaches larger patient populations, pharma teams must balance patient experience, reliable supply chains, and the pressure to launch quickly without sacrificing quality or consistency.

In an interview with OnDrugDelivery, Senior Vice President, Innovation and Product Strategy Bart Burgess explains how SHL Medical is addressing these challenges, and how our Quanta pen injector and Molly autoinjector platforms can support the next generation of these high-demand therapies.

Watch the interview. ⬇️

22/01/2026

Day two at Pharmapack Europe 2026 kept the momentum going. Conversations at Booth quickly shifted from first impressions to how delivery decisions hold up across combination product development.

Quanta stayed a major focus, alongside discussions on:

✔️ Reunite for lyophilized drug delivery
✔️ Maggie for large-volume delivery
✔️ Global development and manufacturing continuity through SHL Medical’s footprint and Alliance network
✔️ Sustainability considerations built into early design and manufacturing decisions

There's still time to catch us at . Stop by to see Quanta and connect with our team.

21/01/2026

Day one at Pharmapack Europe 2026 in Paris set the pace fast. From stage discussions to a busy booth, here’s a quick recap.

🔹 Quanta made its official debut. Our new automatic, multi-fixed-dose pen developed specifically for cardiometabolic therapies quickly became a key talking point throughout the day.

🔹 Our expert sessions drew strong engagement and plenty of audience questions, reflecting increased interest in multi-fixed-dose approaches and development strategy.

🔹 Our co-session with a partner sparked great discussion on cartridge compatibility and what it enables for Maggie, our cartridge-based autoinjector designed for large-volume delivery.

Continue the conversation with us at Booth tomorrow.

20/01/2026

Less than 24 hours to Pharmapack Europe 2026. Final checks, last-minute adjustments, and getting everything ready for the two days ahead.

3 reasons to stop by Booth :

1️⃣ Meet Quanta, SHL Medical's new automatic, multi-fixed-dose pen for once-weekly cardiometabolic treatments.

2️⃣ Explore the thinking behind its multi-fixed-dose approach.

3️⃣ Get a clearer view of where cardiometabolic delivery is heading, and what it means for device strategy.

See you on the show floor.

19/01/2026

Two days to go until Quanta debuts at Pharmapack Europe 2026.

In long-term cardiometabolic treatment, consistency matters. Quanta is designed with this context in mind, offering a fixed-dose approach within an automatic multi-dose pen setup.

Full details will be revealed January 21–22 in Paris. Visit us at Booth for a first look, and meet our team during the product spotlight tour and workshop presentation to learn more about Quanta.

17/01/2026

For the third time, colleagues from SHL Medical, SHL Advantec, and SHL Technologies Ltd. came together to run the Standard Chartered Taipei Charity marathon. 🏃🏻‍♀️‍➡️🏃‍♀️‍➡️

This year, 103 employees showed up at the starting line, many bringing along family and friends, making it an energizing way to kick off 2026. Different distances, different paces, with plenty of encouragement along the way.

The marathon supports programs for disadvantaged youth and Women in Entrepreneurship. By taking part, we added our steps to initiatives that aim to create positive, lasting social impact.

Moments like this reflect how we work at SHL. Whether on the road or at work, progress comes from supporting one another, looking after our health and wellbeing, and delivering together as one community. 💪

Adresse

Zug

Webseite

http://www.shl-medical.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von SHL Medical erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an SHL Medical senden:

Verknüpfungen

Wollen Sie Ihr Praxis zum Top-Klinik in Zug machen?

Our Story

SHL Medical is a world-leading provider of drug delivery solutions. We design, develop, and manufacture advanced drug delivery devices such as autoinjectors, pen injectors, and wearable drug delivery systems. We also offer design-to-build and contract manufacturing services for products such as laboratory handling equipment, neurosurgical devices, and industrial equipment.

By integrating our experienced development teams with efficient manufacturing and a skilled workforce, we have developed a successful business model that allows us to provide comprehensive solutions for demanding requirements of the industry. As the largest company in SHL Group, SHL Medical continues to offer experience, excellence, and vision to customers and partners all over the world.